News
The latest science and news from the Institute.
-
Genetic ‘fine tuning’ controls body’s own attack against breast cancer
5th May 2013
The body’s own immune system’s fight against breast cancer is controlled by genetic ‘fine tuners’, known as microRNAs.
Find out more -
Scientists develop simple blood test to track tumour evolution in cancer patients
2nd May 2013
By tracking changes in patients’ blood, Cambridge scientists have created a new way of looking at how tumours evolve in real-time and develop drug resistance.
Find out more -
Blood test reveals women’s response to breast cancer treatment
13th March 2013
Breast tumour DNA circulating in the bloodstream could be used to measure how well a woman’s cancer is responding to treatment, according to a new study published in the New England Journal of Medicine.
Find out more -
Cancer researchers and astronomers team up to beat cancer
20th February 2013
Cambridge scientists have honed techniques originally developed to spot distant galaxies and used them to identify biomarkers that signal a cancer’s aggressiveness.
Find out more -
Four-stranded ‘quadruple helix’ DNA structure proven to exist in human cells
31st January 2013
Discovery opens up possibilities for a new generation of targeted therapies for cancer.
Find out more -
New technique will transform epigenetics research
26th April 2012
New technique has important implications for stem cell research and the development of regenerative medicines.
Find out more -
Landmark breast cancer study paves way for tailored treatments
18th April 2012
Researchers have identified 10 different types of the disease, laying groundwork for more effective, targeted treatment plans.
Find out more -
Scientists discover how antibiotic molecule found in bacteria stops breast cancer
23rd August 2011
Scientists have discovered how a molecule that was first discovered in bacteria blocks a protein which causes breast cancer to develop and spread.
Find out more -
Scientists crack the code to tamoxifen resistance
13th November 2008
Scientists have discovered the molecular basis for tamoxifen response in breast cancer cells – and the reason why some women can develop resistance to the treatment.
Find out more